💊MDMA for post-traumatic stress disorder

▦ LSD for mood disorders, cluster headache, anxiety in terminally ill patients.

🍄Psilocybin for treatment-resistant depression

🍃Ayahuasca for depression

In recent years, there has been a growing interest in the use of psychedelic substances such as ayahuasca, LSD, MDMA, and psilocybin to aid in the treatment of various mental health conditions, including anxiety disorders, depression, post-traumatic stress disorder, and chemical dependency.

Ayahuasca is made from a combination of the Banisteriopsis caapi (ayahuasca vine) and the leaves of the Psychotria viridis (chacruna) plant and is used in religious rituals in many indigenous cultures in South America. Recent research shows that ayahuasca may aid in the treatment of depression and anxiety, as well as promote an increase in connection with nature and spirituality.

LSD has been studied for therapeutic purposes for many years, with recent studies indicating its potential to aid in the treatment of anxiety and depression disorders, as well as being used to aid in the treatment of patients with chemical dependency.

MDMA is a chemical compound that has stimulant and empathogenic properties. It may be effective in the treatment of anxiety disorders, post-traumatic stress disorder, and depression, allowing patients to process their emotions more easily with the aid of psychotherapy.

Psilocybin is a compound found in certain types of mushrooms that has been studied for many years for its potential therapeutic effects. In addition, it has been used by Amerindians for centuries.

Although these substances may be promising for the treatment of various mental health disorders, it is important to note that their use is not yet regulated in Brazil. Additionally, it is important to remember that these substances are not a panacea and should be used in conjunction with other therapies and treatments to ensure better results.

*Here, I do not discuss substances already in use in Brazil, such as ketamine and ibogaine. Want to learn more?

Felipe De Nadai CRP 08/35704